Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Cancer Therapies02:49

Cancer Therapies

7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Cancer Vaccines01:30

Cancer Vaccines

338
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
338

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Approach to Decision-Making in Nasogastric Tube Weaning and Tracheostomy Tube Decannulation.

Journal of maxillofacial and oral surgery·2021
Same author

Expression of CD 133 in Invasive Ductal Carcinoma of Breast.

Asian Pacific journal of cancer prevention : APJCP·2020
Same author

Deep subfascial approach to the temporal area.

Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons·2012
Same author

Lethal forms of short limb dwarfism.

Indian pediatrics·1995

Related Experiment Video

Updated: Jun 6, 2025

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

1.3K

Proactive Customized Protocol for Oral Management in Head and Neck Cancer Patients Planned for Radiotherapy.

Deepika Kenkere1, Manjunath Narasappa Gudibande2, C Deepa3

  • 1Department of Dentistry, Fellow Oral Oncosurgery, Department of ENT and Head & Neck Surgery, Sri Devaraj Urs Medical College, Tamaka, Kolar India.

Journal of Maxillofacial and Oral Surgery
|December 2, 2024
PubMed
Summary

This study introduces a tailored oral management protocol to reduce osteoradionecrosis (ORN) after radiotherapy. The protocol effectively lowered the incidence of this severe complication in patients treated with telecobalt radiotherapy.

Keywords:
ManagementOralOsteoradionecrosisProtocolRadiotherapy

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.3K
Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System
08:25

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System

Published on: April 11, 2018

15.2K

Related Experiment Videos

Last Updated: Jun 6, 2025

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

1.3K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.3K
Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System
08:25

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System

Published on: April 11, 2018

15.2K

Area of Science:

  • Oncology
  • Radiotherapy
  • Oral Medicine

Background:

  • Osteoradionecrosis (ORN) is a serious complication of radiotherapy, particularly with conventional telecobalt external beam therapy.
  • High incidence of ORN occurs in dentate jaws due to post-radiation odontogenic infections and extractions.
  • Current advanced radiotherapy techniques aim to mitigate ORN, but a specific protocol is needed for conventional methods.

Purpose of the Study:

  • To develop and evaluate a customized oral management protocol to reduce osteoradionecrosis (ORN) in patients undergoing telecobalt radiotherapy.
  • To adapt existing guidelines to local patient demographics and treatment modalities.
  • To assess the effectiveness of the designed protocol in a clinical setting.

Main Methods:

  • Retrospective study of patients undergoing radiotherapy with the implemented oral management protocol.
  • Systematic evaluation of oral tissues before, during, and after radiotherapy.
  • Application of therapeutic and prophylactic measures as per the customized protocol.

Main Results:

  • The implemented oral management protocol was effective in reducing the frequency of osteoradionecrosis.
  • The protocol demonstrated success in a tertiary care hospital setting.
  • Customization of guidelines to patient strata proved beneficial.

Conclusions:

  • A tailored oral management protocol can significantly decrease osteoradionecrosis incidence in patients receiving telecobalt radiotherapy.
  • Proactive and systematic oral care is crucial for managing radiotherapy complications.
  • The developed protocol offers a viable solution for reducing ORN in resource-specific settings.